https://www.avient.com/investor-center/news/polyone-raises-outlook-fourth-quarter-2019-adjusted-earnings
Clariant's
Clariant's
Clariant's
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
Mevopur™ Healthcare Functional Additives
Antistatic Additive
APPLICATION BULLETIN
Plastics often undergo charge build-up, which can
lead to handling problems and electrical discharges.
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/news/avient-site-taiwan-earns-iso-13485-accreditation-fourth-source-mevopur-medical-grade-materials
This is where the MEVOPUR product line, and local availability from Taiwan, become extremely important.”
We aim to limit non-compliance risk and support safety in use by using only raw materials that have been specially tested in accordance with medical standards.
The certification of this fourth MEVOPUR site provides further proof of our commitment to the healthcare industry and to helping our customers achieve their product safety requirements.”
https://www.avient.com/investor-center/news/avient-announces-record-second-quarter-2021-results-increases-full-year-guidance
Condensed Consolidated Balance Sheets
(In millions)
Clariant MB
Clariant MB
https://www.avient.com/news/avient-s-malm-sweden-site-earns-iscc-plus-certification-mevopur-healthcare-bio-based-polymer-solutions
Homepage
//
News Center
//
Avient’s Malmö, Sweden Site Earns ISCC PLUS Certification for Mevopur™ Healthcare Bio-based Polymer Solutions
Mevopur™ Healthcare Bio-based Polymer Solutions manufactured in Malmö, Sweden, are now ISCC PLUS certified.
Like other Mevopur products, the bio-based polymer solutions are formulated with raw materials pre-tested to ISO, USP, EP, and ICH Q3D protocols, supporting their compliance with safety and regulatory requirements for use in healthcare.
https://www.avient.com/investor-center/news/avient-announces-record-fourth-quarter-and-full-year-2021-results
The company acquired Clariant's color ("Clariant Color") business on
Summary of Special Items (Unaudited)(In millions, except per share data)
Condensed Consolidated Balance Sheets (Unaudited)(In millions)
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative.
1.844.4AVIENT
www.avient.com
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/resource-center?document_type=59&page=18
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets
https://www.avient.com/resource-center?document_type=59&page=20
Technical Data Sheets
Safety Data Sheets
Safety Data Sheets